Grippocitron forte powder 4 g. №10

$19.00

Manufacturer: Ukraine

Increased individual sensitivity to any components of the drug or to other antihistamines; severe violations of liver and kidney function; congenital deficiency of glucose-6-phosphate dehydrogenase (as evidenced by hemolytic anemia); severe cardiac conduction disorders; uncompensated heart failure; hyperthyroidism; obstruction of the bladder neck; pyloroduodenal obstruction; intolerance to fructose, galactose; glucose-galactose malabsorption syndrome, lactase or sucrose-isomaltase deficiency; thrombosis; thrombophlebitis; the tendency to thrombosis;

Category:

Description

GRIPPOCITRON FORTE COMPOSITION
active ingredients: paracetamol, ascorbic acid, pheniramine maleate, phenylephrine hydrochloride

1 packet contains paracetamol 650 mg, ascorbic acid 50 mg, pheniramine maleate 20 mg, phenylephrine hydrochloride 10 mg

Excipients:

GRIPPOCITRON FORTE DOSAGE FORM
Powder for oral solution.

GRIPPOCITRON FORTE MAIN PHYSICAL AND CHEMICAL PROPERTIES
the contents of the package are a mixture of granules and powder of yellow and white color with a fruity odor.

PHARMACOLOGICAL GROUP
Analgesics and antipyretics. Paracetamol, combinations without psycholeptics. ATX code N02B E51.

PHARMACOLOGICAL PROPERTIES
Paracetamol has antipyretic, analgesic and anti-inflammatory effects. Suppresses the synthesis of prostaglandins in the central nervous system and blocks the conduction of pain impulses. It is well absorbed, penetrates the placental barrier, penetrates into breast milk in small amounts, is metabolized by the cytochrome P450 system, is excreted by the kidneys, the half-life is 1-4 hours. The duration of action is 3-4 hours.

Ascorbic acid enhances the body’s nonspecific resistance. It is rapidly absorbed in the digestive tract. It is metabolized in the liver, excreted by the kidneys.

Pheniramine maleate – blocker of H 1 receptors, reduces vascular permeability, eliminates lacrimation, itching of the eyes and nose. Well absorbed in the digestive tract. It is metabolized in the liver by the cytochrome P450 system, the half-life is 16-18 hours, 70-83% is excreted by the kidneys.

INDICATIONS
Symptomatic treatment of acute respiratory infections and influenza:

increased body temperature
headache
nasal congestion
runny nose
muscle aches and pains.

CONTRAINDICATIONS
Hypersensitivity to the drug components severe liver and / or kidney dysfunctions congenital hyperbilirubinemia glucose-6-phosphate dehydrogenase deficiency alcoholism, blood diseases leukopenia anemia severe arrhythmias, arterial hypertension, atherosclerosis, ischemic heart disease, hyperthyroidism acute pancreatitis prostatic hypertrophy sertrophy bladder neck pyloroduodenal obstruction bronchial asthma glaucoma thrombosis thrombophlebitis epilepsy states of increased excitement concomitant treatment with MAO inhibitors and 2 weeks after discontinuation of their use.